Evidence map›Paper›PMID 42362957›Full record

ReviewImmunologic research2026

Decoding PANoptosis: Crosstalk of cell death pathways in immunity and inflammation.

K Subashree, Kannan Harithpriya, Goutham V Ganesh, Kunka Mohanram Ramkumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

K SubashreeDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Tamil Nadu, 603203, Kattankulathur, India.
Kannan HarithpriyaDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Tamil Nadu, 603203, Kattankulathur, India.
Goutham V GaneshDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Tamil Nadu, 603203, Kattankulathur, India.
Kunka Mohanram RamkumarDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Tamil Nadu, 603203, Kattankulathur, India. ramkumak@srmist.edu.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PANoptosis is an emerging regulated cell death that integrates the molecular machinery of apoptosis, necroptosis, and pyroptosis into a combined, highly coordinated process. Defined as a distinct, integrative form of cell death, PANoptosis simultaneously engages these three pathways through a multiprotein scaffold known as the PANoptosome, ensuring robust elimination of infected, damaged, or transformed cells. Initially described in response to viral infections, PANoptosis is now recognized as a critical regulator of immune defense, inflammation, and tissue homeostasis, with broad implications for infectious diseases, cancer, autoimmune disorders, neurodegeneration, and ischemia-reperfusion injury. This review provides a comprehensive overview of the molecular composition of the PANoptosome, key triggers of PANoptosis, and its morphological and biochemical hallmarks. We further discuss its dual roles as both a protective and pathogenic mechanism, highlighting context-dependent contributions to host defense and disease progression. Finally, we examine therapeutic opportunities, including small-molecule inhibitors and gene-editing approaches, and outline current challenges, such as the identification of reliable biomarkers and the need for precision-targeted strategies. By integrating recent advances, this review highlights PANoptosis as a conceptual shift in cell death biology and a promising avenue for novel interventions in inflammation-driven diseases.

Indexed as

InflammationNecroptosisAnimalsApoptosisCell DeathHumansPyroptosisSignal TransductionApoptosisCell death pathwayInflammationNecroptosisPANoptosisPyroptosis

Identifiers

PMID42362957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.